123 related articles for article (PubMed ID: 11079163)
1. Monoclonal antibody therapies for lymphomas.
Foon KA
Cancer J; 2000; 6(5):273-8. PubMed ID: 11079163
[TBL] [Abstract][Full Text] [Related]
2. [Development of monoclonal antibody therapy for malignant lymphoma].
Ogura M
Nihon Rinsho; 2002 Mar; 60(3):505-16. PubMed ID: 11904966
[TBL] [Abstract][Full Text] [Related]
3. [Rituximab, a chimeric anti-CD20 monoclonal antibody, in the treatment of B-cell lymphoma].
Tobinai K
Gan To Kagaku Ryoho; 2002 Mar; 29(3):473-80. PubMed ID: 11915743
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibody therapy for malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
Tobinai K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
[TBL] [Abstract][Full Text] [Related]
6. Ibritumomab: new drug. Interesting concept, disappointing in practice.
Prescrire Int; 2005 Oct; 14(79):171-3. PubMed ID: 16285071
[TBL] [Abstract][Full Text] [Related]
7. Rituximab: an insider's historical perspective.
Grillo-López AJ
Semin Oncol; 2000 Dec; 27(6 Suppl 12):9-16. PubMed ID: 11226006
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
9. Rituximab and other emerging monoclonal antibody therapies for lymphoma.
Tobinai K
Expert Opin Emerg Drugs; 2002 Oct; 7(2):289-302. PubMed ID: 15989552
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody as therapy for malignant lymphomas.
Coiffier B
C R Biol; 2006 Apr; 329(4):241-54. PubMed ID: 16644494
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody therapy for lymphoma: an update.
Dillman RO
Cancer Pract; 2001; 9(2):71-80. PubMed ID: 11879282
[TBL] [Abstract][Full Text] [Related]
12. Newer monoclonal antibodies for hematological malignancies.
Castillo J; Winer E; Quesenberry P
Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
14. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Naparstek E
Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies in the treatment of lymphoma].
Mounier N; Gisselbrecht C
Rev Prat; 2002 May; 52(9):982-5. PubMed ID: 12063765
[TBL] [Abstract][Full Text] [Related]
17. Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma.
Grillo-López AJ
Expert Rev Anticancer Ther; 2002 Oct; 2(5):485-93. PubMed ID: 12382517
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.
King KM; Younes A
Expert Rev Anticancer Ther; 2001 Aug; 1(2):177-86. PubMed ID: 12113023
[TBL] [Abstract][Full Text] [Related]
19. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
20. Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
Law CL; Cerveny CG; Gordon KA; Klussman K; Mixan BJ; Chace DF; Meyer DL; Doronina SO; Siegall CB; Francisco JA; Senter PD; Wahl AF
Clin Cancer Res; 2004 Dec; 10(23):7842-51. PubMed ID: 15585616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]